Nash J R, Peters M, Bell P R
Transplantation. 1978 Apr;25(4):180-1. doi: 10.1097/00007890-197804000-00004.
Attempts to improve the induction of immunological enhancement of (AS X August)F1 pancreatic islet allografts in diabetic AS rats have been carried out. First, by treating the diabetic AS recipient with enhancing serum obtained from AS rats with functioning enhanced (AS X August)F1 islet allografts. In these rats on 1 of 5 islet allografts had a prolonged survival, the other 4 being rejected by 2 days. Second, by transplanting (AS X August)F1 islet allografts into diabetic AS rats bearing functioning enhanced (AS X August)F1 cardiac allografts. All of these islet allografts were rejected by 2 days.
已尝试改善在糖尿病AS大鼠中诱导(AS×奥古斯特)F1胰岛同种异体移植免疫增强的情况。首先,用从具有功能增强的(AS×奥古斯特)F1胰岛同种异体移植的AS大鼠获得的增强血清治疗糖尿病AS受体。在这些大鼠中,5个胰岛同种异体移植中有1个存活时间延长,其他4个在2天内被排斥。其次,将(AS×奥古斯特)F1胰岛同种异体移植到具有功能增强的(AS×奥古斯特)F1心脏同种异体移植的糖尿病AS大鼠中。所有这些胰岛同种异体移植在2天内被排斥。